149 related articles for article (PubMed ID: 18497984)
1. Epigenetic modification is involved in aberrant expression of class III beta-tubulin, TUBB3, in ovarian cancer cells.
Izutsu N; Maesawa C; Shibazaki M; Oikawa H; Shoji T; Sugiyama T; Masuda T
Int J Oncol; 2008 Jun; 32(6):1227-35. PubMed ID: 18497984
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
4. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
Kikuchi R; Tsuda H; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
Cancer Res; 2007 Aug; 67(15):7095-105. PubMed ID: 17671176
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
[TBL] [Abstract][Full Text] [Related]
8. [E-cadherin promoter methylation and demethylation in epithelial ovarian carcinoma cells].
Qu PP; Shi Z; Li N
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):538-41. PubMed ID: 19957556
[TBL] [Abstract][Full Text] [Related]
9. Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness.
Raspaglio G; Petrillo M; Martinelli E; Li Puma DD; Mariani M; De Donato M; Filippetti F; Mozzetti S; Prislei S; Zannoni GF; Scambia G; Ferlini C
Gene; 2014 Jun; 542(2):173-81. PubMed ID: 24661907
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer.
Sung HY; Yang SD; Park AK; Ju W; Ahn JH
Yonsei Med J; 2017 Jan; 58(1):27-34. PubMed ID: 27873492
[TBL] [Abstract][Full Text] [Related]
11. MiR-200c and HuR in ovarian cancer.
Prislei S; Martinelli E; Mariani M; Raspaglio G; Sieber S; Ferrandina G; Shahabi S; Scambia G; Ferlini C
BMC Cancer; 2013 Feb; 13():72. PubMed ID: 23394580
[TBL] [Abstract][Full Text] [Related]
12. Identification of candidate methylation-responsive genes in ovarian cancer.
Menendez L; Walker D; Matyunina LV; Dickerson EB; Bowen NJ; Polavarapu N; Benigno BB; McDonald JF
Mol Cancer; 2007 Jan; 6():10. PubMed ID: 17254359
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of MYO18B, a candidate tumor-suppressor gene on chromosome arm 22q, in ovarian cancer.
Yanaihara N; Nishioka M; Kohno T; Otsuka A; Okamoto A; Ochiai K; Tanaka T; Yokota J
Int J Cancer; 2004 Oct; 112(1):150-4. PubMed ID: 15305387
[TBL] [Abstract][Full Text] [Related]
14. RUNX3 gene methylation in epithelial ovarian cancer tissues and ovarian cancer cell lines.
Zhang S; Wei L; Zhang A; Zhang L; Yu H
OMICS; 2009 Aug; 13(4):307-11. PubMed ID: 19645591
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
16. Loss of class III beta-tubulin induced by histone deacetylation is associated with chemosensitivity to paclitaxel in malignant melanoma cells.
Akasaka K; Maesawa C; Shibazaki M; Maeda F; Takahashi K; Akasaka T; Masuda T
J Invest Dermatol; 2009 Jun; 129(6):1516-26. PubMed ID: 19122647
[TBL] [Abstract][Full Text] [Related]
17. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
18. [Apoptosis and re-expression of p16 gene in the myeloma cell line U266 induced by synergy of histone deacetylase inhibitor and demethylating agent].
Du HL; Qi Y; Shi YJ; Bu DF; Wu SL
Ai Zheng; 2002 Oct; 21(10):1057-61. PubMed ID: 12508642
[TBL] [Abstract][Full Text] [Related]
19. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
Meng CF; Dai DQ; Guo KJ
Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells.
Law AY; Lai KP; Ip CK; Wong AS; Wagner GF; Wong CK
Exp Cell Res; 2008 May; 314(8):1823-30. PubMed ID: 18394600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
